Transdermal is better than oral: observational research of the satisfaction of caregivers of patients with Alzheimer's disease treated with rivastigmine.
about
Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysisPersistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factorsThe Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.Combination therapy with cholinesterase inhibitors and memantine for Alzheimer's disease: a systematic review and meta-analysisProtection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled TrialsReal-world evaluation of compliance and preference in Alzheimer's disease treatment.Real-world evaluation of compliance and preference in Alzheimer's disease treatment: an observational study in Taiwan.Oral drug therapy in elderly with dysphagia: between a rock and a hard place!Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis.Lithium as a Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis.Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease.Caregiver Preference and Treatment Compliance in Patients with Mild-to-Moderate Alzheimer's Disease in South Korea: RECAP Study Results.Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease.Which rivastigmine formula is better for heart in elderly patients with Alzheimer's disease: oral or patch?
P2860
Q26861399-BD11CA7D-D266-4D10-B2D8-D0A74A5359C8Q26997299-53FB68FB-76D5-4D90-9169-635007B01B47Q33165801-286F11B9-2572-44A6-BAB4-0B93F276AD6CQ35224319-864C1ED4-4B6D-4B68-B885-5D93DD82F70EQ35669030-F34E2593-EACB-4703-A3B9-A11BBEB4D977Q36264977-00815005-B8E2-4DC5-9935-230F9833CF5CQ36766861-EC4EE755-B983-4BB8-911B-7D462817849CQ37626330-52F141B5-559C-4770-A168-0A5BD123E025Q38556646-49983A2D-3818-402E-BAC0-754DD2753930Q38592137-2B67F08C-0870-4E6C-A0E1-DDBC62C4B51CQ38906350-8858E1F1-3550-4796-A27F-0F9D0D33425EQ39079324-016276FE-085A-4F6C-B731-FCF40C5A8551Q51491144-472116B5-05CE-4382-964D-1FE4C27D7462Q53464972-2669DB37-6D59-4A79-A52C-3139A31A538D
P2860
Transdermal is better than oral: observational research of the satisfaction of caregivers of patients with Alzheimer's disease treated with rivastigmine.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Transdermal is better than ora ...... ase treated with rivastigmine.
@en
Transdermal is better than ora ...... ase treated with rivastigmine.
@nl
type
label
Transdermal is better than ora ...... ase treated with rivastigmine.
@en
Transdermal is better than ora ...... ase treated with rivastigmine.
@nl
prefLabel
Transdermal is better than ora ...... ase treated with rivastigmine.
@en
Transdermal is better than ora ...... ase treated with rivastigmine.
@nl
P2860
P356
P1476
Transdermal is better than ora ...... ase treated with rivastigmine.
@en
P2093
Francisco Javier Arranz
Mercè Boada
P2860
P356
10.1159/000345989
P577
2013-01-09T00:00:00Z